| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 725098 | Null | 0.0392716453377535 | 0.44977602 |
| NSC 726217 | Combretastatin A4-analogue | 0.0392716453377535 | 0.41954167 |
| NSC 726442 | 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride | 0.0392716453377535 | 0.46503542 |
| NSC 727620 | 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride | 0.0392716453377535 | 0.39735075 |
| NSC 732205 | Null | 0.0392716453377535 | 0.51870107 |
| NSC 734287 | 6-(3-Aminopropyl)-5,6-dihydro-7,8,9-trimethoxy-3-nitro-5,11- dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.0392716453377535 | 0.22988832 |
| NSC 734949 | 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide | 0.0392716453377535 | 0.40027829 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.0392716453377535 | 0.34968397 |
| NSC 743532 | Null | 0.0392716453377535 | 0.032187953 |
| NSC 744023 | (11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.0392716453377535 | 0.3470352 |